Related Experiment Video
Updated: Mar 5, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Molecular dynamics simulations elucidate conformational selection and induced fit mechanisms in the binding of PD-1
Wenping Liu1, Bing Huang, Yashu Kuang
1School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
Abstract:
Blockage of the interactions between immunologic checkpoint protein PD-1 and its ligand PD-L1 showed efficacy for cancer treatment. X-ray structures have captured static conformational snapshots of PD-1 and revealed that the CC' loop adopts an open conformation in the apo-protein but turns into a closed form and interacts with PD-L1 in the complex. This structural heterogeneity brings difficulties for structure-based drug discovery targeting PD-1. To gain insights into the role of the CC' loop in molecular recognition, we have undertaken a comparative study between the open and closed conformations in apo-PD-1 and the PD-1/PD-L1 complex using molecular dynamics simulations. Results show that the moderate stability of intramolecular hydrogen bonds between SER71 and THR120 allows the CC' loop to sample both the open and closed states in apo-PD-1. Binding of PD-L1 accelerates the open-to-closed switch and locks the loop in the closed state through four newly formed intermolecular hydrogen bonds. Thus, we suggest a complex binding mechanism between PD-1 and PD-L1 where both the conformational selection and induced fit theories play a role.
Insights
Blocking the interaction between programmed cell death protein 1 (PD-1) and its ligand PD-L1 is effective for cancer treatment. Molecular dynamics simulations reveal PD-1’s CC’ loop flexibility is key to PD-L1 binding, involving both conformational selection and induced fit.
Area of Science:
- Immunology
- Structural Biology
- Computational Biology
Background:
- Immune checkpoint inhibitors targeting the programmed cell death protein 1 (PD-1) and its ligand PD-L1 pathway have shown significant promise in cancer therapy.
- Structural studies of PD-1 reveal conformational flexibility, particularly in the CC' loop, which transitions between open and closed states.
Purpose of the Study:
- To investigate the role of the CC' loop's conformational dynamics in the molecular recognition between PD-1 and PD-L1.
- To elucidate the binding mechanism by comparing apo-PD-1 and the PD-1/PD-L1 complex.
Main Methods:
- Molecular dynamics simulations were employed to compare the open and closed conformations of the CC' loop in apo-PD-1 and the PD-1/PD-L1 complex.
- Analysis focused on hydrogen bonding patterns and conformational transitions.
Main Results:
- The CC' loop in apo-PD-1 can access both open and closed states due to the moderate stability of intramolecular hydrogen bonds (SER71-THR120).
- PD-L1 binding promotes a rapid switch to the closed conformation and stabilizes it via four new intermolecular hydrogen bonds.
- This suggests a binding mechanism involving both conformational selection and induced fit.
Conclusions:
- The conformational flexibility of the PD-1 CC' loop is a critical determinant in its interaction with PD-L1.
- Understanding this dynamic interplay is crucial for the rational design of novel structure-based drugs targeting the PD-1/PD-L1 axis for cancer immunotherapy.
More Related Videos
09:40Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
The Equilibrium Binding Constant and Binding Strength
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...